FILE PHOTO: Empty vials of AstraZeneca COVID-19 vaccine are seen in a tray during a mass vaccination campaign at Atletico Madrid's Wanda Metropolitano stadium in Madrid, Spain, February 25, 2021. REUTERS/Sergio Perez/File Photo
RIO DE JANEIRO (Reuters) - Preliminary studies suggest the AstraZeneca vaccine will protect against the P1 variant of the coronavirus, Mauricio Zuma, the head of production at Brazil's Fiocruz biomedical institute said on Monday, confirming a Reuters report on Friday.
The Brazil variant is worrying experts because it is highly contagious and has led several countries to ban travel from the Latin American nation.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
